Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
about
Type 1 plasminogen activator inhibitor (PAI-1) in clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomyThe prognostic molecular markers in hepatocellular carcinoma.Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasiaIndependent prognostic value of angiogenesis and the level of plasminogen activator inhibitor type 1 in breast cancer patientsA cross-talk between NFAT and NF-κB pathways is crucial for nickel-induced COX-2 expression in Beas-2B cellsTransforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.Liposomal nanomedicine for breast cancer therapy.Assessing Tumor Angiogenesis in Histological Samples.Lack of association between level of Plasminogen Activator Inhibitor-1 and estimates of tumor angiogenesis in early breast cancer
P2860
Q33762745-8A3255F8-F0D3-4EF4-A087-357AF66D2842Q34668320-460596F0-08D1-441D-BBDD-9E78DF027AE0Q34996841-10551253-0E75-4432-AD13-1A79C84356E2Q36067470-EA39890F-1446-4A98-8969-E02FA2CE60F4Q36647843-0EE324B5-E555-49ED-B014-64434F2F4BC9Q37137516-920097F4-877D-44EC-9B6F-3F9606749ACDQ37392608-A8524CE2-42FD-4D74-B49B-C5A655F61BC1Q37939968-CE67ECDF-8910-426D-93C1-1F90DA4B8931Q51525609-C51F9FF0-7243-40E9-9DCB-B9B0B5767303Q57581296-7C0F98AF-48CA-4282-9CB1-19CC9A525FCE
P2860
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
@en
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
@nl
type
label
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
@en
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
@nl
prefLabel
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
@en
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
@nl
P2093
P2860
P356
P1476
Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
@en
P2093
Grøndahl-Hansen J
Kakolyris S
P2860
P304
P356
10.1002/PATH.931
P577
2001-09-01T00:00:00Z